(NaturalNews) After engaging in more than 30 years of vicious and relentless persecution, the Texas Medical Board (TMB) has finally decided to drop its weapons and leave cancer treatment innovator Dr. Stanislaw Burzynski alone, according to new reports. The surprising capitulation came after a panel of judges from the Texas State Office of Administrative Hearings (TSOAH) recently decided to dismiss the TMB's latest lawsuit against Dr. Burzynski, ruling that its allegations against him were invalid.
Throughout the past several years, Dr. Burzynski has had to deflect what seemed like a never-ending onslaught of accusations that he is somehow breaking the law by treating cancer patients with his novel antineoplastons protocol. And for a while there, it seemed as though the medical system in Texas, backed by the clout and bankroll of the U.S. Food and Drug Administration (FDA), would eventually win its crusade against Dr. Burzynski by eventually withdrawing his medical license and shutting down his clinic.
But the tides appear to have turned, and the TMB seems to have backed off, at least for now. In a recent letter obtained by consumer advocate Tim Bolen, Dr. Burzynski's attorney, Rick Jaffe, explains that the TMB's investigation into Dr. Burzynski slowly came to a grinding halt after TMB settlement panels back in 2008 first dismissed allegations that Dr. Burzynski's antineoplastons were outside the proper standard of care. The TMB refused to back down at the time, and decided to file a formal complaint against Dr. Burzynski. But that approach also failed.
"On November 19, 2012, judges of the Texas State Office of Administrative Hearings dismissed the Texas Medical Board's pending case against Dr. Burzynski," explained Jaffe in an email to the Bolen Report. "The cutting-edge, multi-agent gene targeted therapy devised by Dr. Burzynski which was at the heart of this proceeding is still being given at the clinic and is helping countless patients."
What made this all possible is the fact that the TMB no longer has the power to arbitrarily overturn TSOAH decisions, which has greatly stunted the group's ability to maliciously target cutting-edge medical practices like Dr. Burzynski's that it simply does not like. No longer does the TMB have the same level of power to bully those with which it disagrees, in other words, which in this case has long been centered on Dr. Burzynski.
"I'm glad we didn't have to spend three weeks on a trial," added Jaffe. "It would have been a complete waste of time and money."